Activation of murine peritoneal macrophages after cisplatin and taxol combination

Anti-Cancer Drugs

Volumn 8, Issue 8, 1997, Pages 784-789

  Muenchen, Heather J ^a   Aggarwal, Surinder K ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Cisplatin; In vitro; Interleukin 1 ; Lysosomes; Macrophages; Taxol; Tumor necrosis factor

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; INTERLEUKIN 1ALPHA; PACLITAXEL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SARCOMA 180; TUMOR NECROSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CISPLATIN; CYTOTOXICITY, IMMUNOLOGIC; DRUG COMBINATIONS; INTERLEUKIN-1; LYSOSOMES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; PACLITAXEL; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030870651     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199709000-00008     Document Type: Article

References (19)

1. Wall ME, Wani MC. Camptothecin and taxol: discovery to clinical-the thirteenth Bruce F Cain Memorial Award Lecture. Cancer Res 1995; 55: 753.
2. Hajek R. Paclitaxel. Cas-Lek-Cesk 1996; 135: 393.
3. Nicolini M. Platinum and other metal coordination compounds in cancer chemotherapy. Boston: Martinus Nijhoff 1990.
4. Roberts JJ, Pascoe JM. Cross-linking of complementary strands of DNA in mammalian cells by antitumor platinum compounds. Nature 1972; 235: 282.
5. Adams D. Hamilton T. Activation of macrophages for tumor cell kill: Effector mechanisms and regulation. In: Heppner GH, Fulton AM, eds. Macrophages and cancer. Boca Raton, FL: CRC Press 1988: 27.
6. Carleton S, Stevenson A, Hibbs J. Effector mechanisms for macrophage-induced cytostasis and cytolysis of tumor cells. In: Heppner GH. Fulton AM, eds. Macrophages and cancer. Boca Raton, FL: CRC Press 1988: 39.
7. Palam JP, Aggarwal SK. Cisplatin and carboplatin mediated activation of murine peritoneal macrophages in vitro: production of interleukin-1 and tumor necrosis factor. Anti-Cancer Drugs 1995; 6: 1.
8. Rowinsky EK, Citarrdi MJ, Noe CA. Donehower RC. Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotuble agents taxol and vincristine. J Cancer Res Clin Oncol 1993; 119: 727.
9. Meager A. RIA, IRMA, and ELISA assays for cytokinse. In: Balkwill F, ed. Cytokines: a practical approach. Oxford: Oxford University Press 1991: 299.
10. Poole A. The detection of lysosomes by vital staining with acridine orange. In: Dingle J, ed. Lysosomes, a laboratory handbook. Amsterdam: Elsevier/North Holland Biomedical Press 1977: 313
11. Parker RJ, Dabholkar MD, Lee KB, Bostick-Bruton F, Reed E. Taxol effect on cisplatin sensitivity and cisplatin cellular accumulation in human ovarian cancer cells. Monogr Natl Cancer Inst 1993; 15: 83.
12. Donaldson KL, Goolsby GL, Wahl AF. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int J Cancer 1994; 57: 847.
13. Kumar R, Shrivastava A, Sodhi A. Cisplatin stimulates protein tyrosine phosphoiylation in macrophages. Biochem Mol Biol Int 1995; 35: 541.
14. Gery I, Waksman B. Potentiation of cultured mouse thymocyte response by factors released by peripheral leukocytes. J Immunol 1986; 107: 1778.
15. Palma JP, Aggarwal SK. Cisplatin and carboplatin mediated release of cytolytic factors in murine peritoneal macrophages in vitro. Anti-Cancer Drugs 1994; 5: 615.
16. Bucana C, Hoyer L, Hobbs B, et al. Morphological evidence for translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells. Cancer Res 1976; 36: 4444.
17. Hibbs J. Heterocytolysis by macrophages activated by bacmus calmette guerin: lysosome exocytosis into tumor cells. Science 1974; 148: 468.
18. Palma JP, Aggarwal SK, Jiwa A. Murine macrophage activation after cisplatin or carboplatin treatment. Anti-Cancer Drugs 1992; 3: 665.
19. Singh S, Sodhi A. Interaction between cisplatin treated macrophages and Dalton's lymphoma cells in vitro. Exp Cell Biol 1989; 56: 1.